Harel Insurance Investments & Financial Services Ltd. Has $7.03 Million Position in Chemed Corporation $CHE

Harel Insurance Investments & Financial Services Ltd. cut its holdings in Chemed Corporation (NYSE:CHE) by 7.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,615 shares of the company’s stock after selling 1,394 shares during the period. Harel Insurance Investments & Financial Services Ltd. owned 0.14% of Chemed worth $7,032,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in CHE. SG Americas Securities LLC grew its stake in shares of Chemed by 773.5% in the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after acquiring an additional 23,436 shares during the last quarter. BNP Paribas Financial Markets raised its stake in Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after purchasing an additional 4,430 shares during the last quarter. TD Asset Management Inc raised its stake in Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after purchasing an additional 22,715 shares during the last quarter. Abacus FCF Advisors LLC bought a new stake in Chemed in the 4th quarter valued at $5,935,000. Finally, C WorldWide Group Holding A S acquired a new stake in Chemed in the 4th quarter worth $2,189,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Bank of America upped their target price on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research note on Thursday, July 9th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Royal Bank Of Canada increased their target price on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $480.25.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 3.33% of the company’s stock.

Chemed Trading Up 0.2%

CHE stock opened at $492.96 on Thursday. The business has a fifty day moving average price of $447.15 and a 200 day moving average price of $429.88. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $497.25. The stock has a market capitalization of $6.54 billion, a price-to-earnings ratio of 26.86, a P/E/G ratio of 1.81 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed (NYSE:CHE) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the prior year, the business earned $5.63 earnings per share. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts expect that Chemed Corporation will post 22.67 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.